Literature DB >> 10233672

Movement disorders in encephalitis induced by Rhodococcus aurantiacus infection relieved by the administration of L-dopa and anti-T-cell antibodies.

Y Min1, M Asano, M Kohanawa, T Minagawa.   

Abstract

Mice injected with Rhodococcus aurantiacus by the intravenous (i.v.) route show neurological disorders, hemiparesis, vertical headshake and turn-round gait after day 7 postinfection (p.i.). Neurological symptoms caused by i.v. inoculation of R. aurantiacus were relieved by treatment with levodopa (l-dopa). R. aurantiacus was isolated from the brain and was found to be completely eliminated at day 7 p. i. Focal encephalitis was mainly observed in the brain stem, and T cells could be isolated from the brain after day 7 p.i. Administration of both an anti-CD4 monoclonal antibody (mAb) and an anti-CD8 mAb suppressed neurological symptoms. These results suggest that R. aurantiacus induces movement disorders in mice, and that the symptoms are mediated by T cells infiltrating the brain, rather than directly by the bacterium.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10233672      PMCID: PMC2326717          DOI: 10.1046/j.1365-2567.1999.00659.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  16 in total

1.  Reciprocal action of interferon-gamma and interleukin-4 promotes granulomatous inflammation induced by Rhodococcus aurantiacus in mice.

Authors:  M Asano; M Kohanawa; T Minagawa; A Nakane
Journal:  Immunology       Date:  1996-07       Impact factor: 7.397

Review 2.  Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens.

Authors:  J A Ledbetter; L A Herzenberg
Journal:  Immunol Rev       Date:  1979       Impact factor: 12.988

3.  L-dopa-responsive movement disorder caused by Nocardia asteroides localized in the brains of mice.

Authors:  S Kohbata; B L Beaman
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

4.  Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule.

Authors:  D P Dialynas; Z S Quan; K A Wall; A Pierres; J Quintáns; M R Loken; M Pierres; F W Fitch
Journal:  J Immunol       Date:  1983-11       Impact factor: 5.422

Review 5.  MS: a CNS and systemic autoimmune disease.

Authors:  D A Hafler; H L Weiner
Journal:  Immunol Today       Date:  1989-03

6.  Characterization of individual tumor necrosis factor alpha-and beta-producing cells after polyclonal T cell activation.

Authors:  U Andersson; G Adolf; M Dohlsten; G Möller; H O Sjögren
Journal:  J Immunol Methods       Date:  1989-10-24       Impact factor: 2.303

7.  Monocytes/macrophages isolated from the mouse central nervous system contain infectious Theiler's murine encephalomyelitis virus (TMEV).

Authors:  R J Clatch; S D Miller; R Metzner; M C Dal Canto; H L Lipton
Journal:  Virology       Date:  1990-05       Impact factor: 3.616

8.  Activation of microglial cells by beta-amyloid protein and interferon-gamma.

Authors:  L Meda; M A Cassatella; G I Szendrei; L Otvos; P Baron; M Villalba; D Ferrari; F Rossi
Journal:  Nature       Date:  1995-04-13       Impact factor: 49.962

9.  Parkinson's disease and immunological abnormalities: increase of HLA-DR expression on monocytes in cerebrospinal fluid and of CD45RO+ T cells in peripheral blood.

Authors:  U Fiszer; E Mix; S Fredrikson; V Kostulas; H Link
Journal:  Acta Neurol Scand       Date:  1994-09       Impact factor: 3.209

10.  Sequential involvement of NK cells and CD8+ T cells in granuloma formation of Rhodococcus aurantiacus-infected mice.

Authors:  M Asano; A Nakane; M Kohanawa; T Minagawa
Journal:  Microbiol Immunol       Date:  1995       Impact factor: 1.955

View more
  2 in total

1.  Tsukamurella strandjordae sp. nov., a proposed new species causing sepsis.

Authors:  M M Kattar; B T Cookson; L D Carlson; S K Stiglich; M A Schwartz; T T Nguyen; R Daza; C K Wallis; S L Yarfitz; M B Coyle
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

2.  The oral microbiome of early stage Parkinson's disease and its relationship with functional measures of motor and non-motor function.

Authors:  Dragos Mihaila; Jordan Donegan; Sarah Barns; Daria LaRocca; Qian Du; Danny Zheng; Michael Vidal; Christopher Neville; Richard Uhlig; Frank A Middleton
Journal:  PLoS One       Date:  2019-06-27       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.